A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF-γ

Annals of Clinical Microbiology and Antimicrobials

Volumn 4, Issue , 2005, Pages

  Mamishi, Setareh ^a   Zomorodian, Kamiar ^a   Saadat, Farshid ^a   Gerami Shoar, Mohsen ^a   Tarazooie, Bita ^a   Siadati, Seyad Ahmad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CEFALEXIN; COTRIMOXAZOLE; GAMMA INTERFERON; POTASSIUM CHLORIDE; RIFAMPICIN;

ARTICLE; ASPERGILLOSIS; BONE BIOPSY; CASE REPORT; CELL FUNCTION; CHRONIC GRANULOMATOUS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPOKALEMIA; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RATE; LIVER ABSCESS; MALE; OSTEOMYELITIS; PHAGOCYTE; PRESCHOOL CHILD; QUALITY OF LIFE; TREATMENT OUTCOME;

AMPHOTERICIN B; ASPERGILLOSIS; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTERFERON TYPE II; MALE;

EID: 26844513760     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-4-4     Document Type: Article

References (12)

1. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79(3):155-69.
2. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH: Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981, 71(1):59-66.
3. Johnston RB Jr: Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2001, 8(1):17-22.
4. Kibbler C: Aspergillus: the invisible threat. Nurs Times 2003, 99(48):48-50.
5. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology 4th edition. New York: WB Saunders Company; 2000:452-453.
6. Rosen F, Geha R: Case studies in immunology: A clinical companion 3rd edition. New York: Garland publishing; 2001:124-126.
7. Dotis J, Roilides E: Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004, 8(2):103-10.
8. Bodur H, Ozoran K, Colpan A, Balaban N, Tabak N, Tabak Y, Kulacoglu S: Arthritis and Osteomyelitis due to Aspergillus fumigatus: A 17 years old boy with chronic granulomatous disease. Ann Clin Microbiol Antimicrob 2003, 2(1):2
9. Dotis J, Panagopoulou P, Filioti J, Winn R, Toptsis C, Pantelliadia C, Roilides E: Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 2003, 31(2):121-4.
10. Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, Malech HL, Gallin JI, Holland SM: Long-term interferongamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 2004, 39(5):692-9.
11. Stasia MJ, Bordigoni P, Floret D, Brion JP, Bost-Bru C, Michel G, Gatel P, Durant-Vital D, Voelckel MA, Li XJ, Guillot M, Maquet E, Martel C, Morel F: Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet 2005, 116:72-82.
12. Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, Eisenstein EM, Turner ML, DeCarlo ES, Starling JM, Holland SM: Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003, 348(24):2416-22.